eGFR is an estimate — not a measurement. CKD is a diagnosis that requires chronicity, not a single number. Pair eGFR with albuminuria and the clinical context before drawing conclusions.
CLINICAL PRINTABLE
Coming Soon.
A one-page eGFR clinical reference is on the way.
1 · What the Result Actually Means
eGFR is an estimate of filtration, usually derived from serum creatinine plus demographic variables. CKD requires abnormalities of kidney structure or function present for at least 3 months. eGFR should be interpreted with chronicity, albuminuria, and other markers of kidney damage — not as a one-number diagnosis.
A single eGFR below 60 on one lab panel does not establish CKD. It establishes that filtration is estimated to be reduced at that moment — which may reflect acute illness, volume depletion, a medication effect, or true chronic disease. Distinguishing these requires context and time.
2 · Practical Interpretation Framework
Ask whether the value is acute or chronic. Compare prior creatinine/eGFR values across at least 3 months when diagnosing CKD. A single value is insufficient.
Pair eGFR with urine albumin-to-creatinine ratio (ACR). GFR category and albuminuria category together improve risk stratification and guide management decisions.
Look for other markers of kidney damage: persistent hematuria of renal origin, structural abnormalities on imaging, electrolyte or tubular disorders, histologic disease, or transplant history.
Remember that creatinine-based eGFR is less reliable when creatinine generation is atypical — very low or high muscle mass, amputation, severe malnutrition, or rapidly changing kidney function.
Use eGFR for medication decisions only with the specific drug's labeling and guidance. Some dosing recommendations use creatinine clearance (Cockcroft-Gault) rather than eGFR — they are not interchangeable for all drugs.
Trend matters. A sustained decline, large unexpected change, or discordance with the clinical picture deserves evaluation.
3 · Nuance That Changes the Interpretation
Age-related decline in GFR can occur, but persistent eGFR below 60 still meets a CKD criterion when chronic. The implications depend heavily on albuminuria and overall risk — not the number alone.
eGFR is unreliable in evolving AKI because serum creatinine is not at steady state. A rapidly rising creatinine underestimates the true degree of filtration loss; a recovering creatinine may overestimate it.
Cystatin C can improve GFR estimation in selected patients when creatinine is likely misleading or diagnostic precision matters — particularly in patients with very low or high muscle mass.
An eGFR above 60 does not exclude CKD when albuminuria or another marker of kidney damage is present. CKD staging is not just G1–G5; albuminuria categories materially change prognosis.
4 · What Should Raise Concern
Rapid or sustained decline in eGFR, especially with active urine findings or systemic disease — this requires evaluation, not watchful waiting.
eGFR decline with significant albuminuria, refractory hypertension, electrolyte abnormalities, or unclear etiology.
Possible AKI being mislabeled as CKD because only the current eGFR is visible — always look for prior values.
Apply It · Patient Scenarios
CASE 1
A healthy 72-year-old has eGFR 58 during an acute GI illness. Prior eGFR 8 months ago was 76.
CLINICAL REASONING
This single result does not establish CKD. The acute illness may be affecting filtration. Repeat after recovery and assess for persistent kidney abnormalities before applying a CKD diagnosis.
CASE 2
A patient has eGFR 52, 50, and 51 over 8 months plus urine ACR 420 mg/g.
CLINICAL REASONING
This is chronic kidney disease with significant albuminuria — a very different risk profile from an isolated eGFR of 58. The combination of sustained reduced filtration and significant albuminuria places this patient in a high-risk CKD category requiring active management.
NOW CHANGE ONE DETAIL
Same patient as Case 2. Now eGFR is 78 but ACR is persistently 500 mg/g.
UPDATED REASONING
Do not dismiss kidney disease because filtration remains above 60. Persistent significant albuminuria meets CKD criteria regardless of eGFR. The albuminuria category materially changes prognosis and management.
This is the clinical scenario where relying on eGFR alone leads to missed diagnoses and delayed intervention.
Understand It · The Nuance
eGFR is a derived estimate from a surrogate marker. Its limitations are predictable — and knowing them prevents misclassification in both directions.
Age-related decline and CKD criteria
Age-related decline in GFR can occur, but persistent eGFR below 60 still meets a CKD criterion when chronic. The implications depend heavily on albuminuria and overall risk — not the number alone.
eGFR in evolving AKI
eGFR is unreliable in evolving AKI because serum creatinine is not at steady state. A rapidly rising creatinine underestimates the true degree of filtration loss; a recovering creatinine may overestimate it.
Cystatin C as an alternative
Cystatin C can improve GFR estimation in selected patients when creatinine is likely misleading or diagnostic precision matters — particularly in patients with very low or high muscle mass.
Normal eGFR does not exclude CKD
An eGFR ≥60 does not exclude CKD when albuminuria or another marker of kidney damage is present. CKD staging is not just G1–G5; albuminuria categories materially change prognosis and management.
Drug dosing and eGFR vs CrCl
Drug dosing adjustments use eGFR or creatinine clearance (Cockcroft-Gault) depending on the specific drug's labeling. These are not interchangeable for all medications — know which equation applies.
Clinical Pearl: Never interpret eGFR without asking: Is it chronic? What is the albuminuria? Does creatinine accurately represent this patient?
Bottom Line
Never interpret eGFR without asking: Is it chronic? What is the albuminuria? Does creatinine accurately represent this patient?
One eGFR below 60 does not establish CKD — chronicity requires at least 3 months of abnormalities.
Always compare with prior values. Acute illness, volume depletion, and medications can transiently reduce eGFR.
Pair eGFR with urine ACR. GFR category and albuminuria category together determine risk and management.
eGFR above 60 does not exclude CKD when albuminuria or another marker of kidney damage is present.
Creatinine-based eGFR is less reliable in patients with atypical muscle mass — consider cystatin C when precision matters.
eGFR is unreliable in evolving AKI — creatinine is not at steady state.
Escalate when the clinical picture, trajectory, or red flags indicate a higher level of care.
EVIDENCE & REFERENCES
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117–S314. doi:10.1016/j.kint.2023.10.018
- Inker LA, Titan S. Measurement and estimation of GFR for use in clinical practice: core curriculum 2021. Am J Kidney Dis. 2021;78(5):736–749. doi:10.1053/j.ajkd.2021.04.016